Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 67 medicines
Health Canada · 47 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 22 medicines
MS · 16 medicines · Historical list
FDA · 16 medicines
SFDA · 12 medicines · Historical list
AEMPS · 7 medicines
HSA · 6 medicines
PHARMAC · 5 medicines
Show all 5ALIMS · 5 medicines
HALMED · 4 medicines
AIFA · 4 medicines
TFDA · 3 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
216 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Carbamazepine | United States | 100MG/5ML | suspension | Marketed | Chartwell RX |
| Carbamazepine | United States | 100MG, 200MG, 400MG | tablet, extended release | Marketed | Osmotica Pharm US |
| Carbamazepine | United States | 100MG, 200MG | tablet, chewable | Marketed | Taro Pharm Inds |
| Carbamazepine | United States | 100MG, 200MG, 300MG | capsule, extended release | Marketed | Teva Pharms |
| Carbamazepine | United States | 100MG, 200MG, 300MG … | tablet | Marketed | RK Pharma |
| Carbamazepine CF 200 mg, tabletten | Netherlands | Tablet | Authorised | Centrafarm B.V. | |
| Carbamazepine Mylan 200 mg, tabletten | Netherlands | Tablet | Authorised | Mylan B.V. | |
| Carbamazepine 100 mg Focus Care, tabletten | Netherlands | Tablet | Authorised | Focus Care Pharmaceuticals B.V. | |
| Carbamazepine 200 mg Focus Care, tabletten | Netherlands | Tablet | Authorised | Focus Care Pharmaceuticals B.V. | |
| Carbamazepine Umedica 100 mg, tabletten | Netherlands | Tablet | Authorised | Umedica Netherlands B.V. | |
| Carbamazepine Umedica 200 mg, tabletten | Netherlands | Tablet | Authorised | Umedica Netherlands B.V. | |
| Carbamazepine Umedica 400 mg, tabletten | Netherlands | Tablet | Authorised | Umedica Netherlands B.V. | |
| Carbamazepine Aurobindo 100 mg, tabletten | Netherlands | Tablet | Authorised | Aurobindo Pharma B.V. | |
| Carbamazepine Aurobindo 200 mg, tabletten | Netherlands | Tablet | Authorised | Aurobindo Pharma B.V. | |
| Carbamazepine CR | Canada | 200 MG | Tablet (Extended-Release) | Cancelled | Pro Doc Limitee |
| Carbamazepine CR | Canada | 400 MG | Tablet (Extended-Release) | Cancelled | Pro Doc Limitee |
| Carbamazepine Tillomed 200 mg tabletten met verlengde afgifte | Netherlands | Tablet met verlengde afgifte | Authorised | Tillomed Pharma GmbH | |
| Carbamazepine Tillomed 400 mg tabletten met verlengde afgifte | Netherlands | Tablet met verlengde afgifte | Authorised | Tillomed Pharma GmbH | |
| Carbamazepine Aurobindo retard 200 mg, tabletten met verlengde afgifte | Netherlands | Tablet met verlengde afgifte | Authorised | Aurobindo Pharma B.V. | |
| Carbamazepine Aurobindo retard 400 mg, tabletten met verlengde afgifte | Netherlands | Tablet met verlengde afgifte | Authorised | Aurobindo Pharma B.V. | |
| Carbamazepine Sandoz retard tablet 200, tabletten met gereguleerde afgifte 200 mg | Netherlands | Tablet met gereguleerde afgifte | Authorised | Sandoz B.V. | |
| Carbamazepine Sandoz retard tablet 400, tabletten met gereguleerde afgifte 400 mg | Netherlands | Tablet met gereguleerde afgifte | Authorised | Sandoz B.V. | |
| Carbamazepine Retard 200 mg Focus Care, tabletten met gereguleerde afgifte | Netherlands | Tablet met gereguleerde afgifte | Authorised | Focus Care Pharmaceuticals B.V. | |
| Carbamazepine Retard 400 mg Focus Care, tabletten met gereguleerde afgifte | Netherlands | Tablet met gereguleerde afgifte | Authorised | Focus Care Pharmaceuticals B.V. | |
| Mint-Carbamazepine | Canada | 200 MG | Tablet | Marketed | Mint Pharmaceuticals INC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
